MDS occurs primarily in older adults; median age at diagnosis is 70-75 years.[9]Sekeres MA, Taylor J. Diagnosis and treatment of myelodysplastic syndromes: a review. JAMA. 2022 Sep 6;328(9):872-80.
http://www.ncbi.nlm.nih.gov/pubmed/36066514?tool=bestpractice.com
[10]Roman E, Smith A, Appleton S, et al. Myeloid malignancies in the real-world: occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol. 2016 Jun;42:186-98.
https://www.sciencedirect.com/science/article/pii/S1877782116300364
http://www.ncbi.nlm.nih.gov/pubmed/27090942?tool=bestpractice.com
MDS is more common in males than in females (approximately 2:1).[10]Roman E, Smith A, Appleton S, et al. Myeloid malignancies in the real-world: occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol. 2016 Jun;42:186-98.
https://www.sciencedirect.com/science/article/pii/S1877782116300364
http://www.ncbi.nlm.nih.gov/pubmed/27090942?tool=bestpractice.com
[11]Killick SB, Wiseman DH, Quek L, et al. British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes. Br J Haematol. 2021 Jul;194(2):282-93.
https://onlinelibrary.wiley.com/doi/10.1111/bjh.17621
http://www.ncbi.nlm.nih.gov/pubmed/34137023?tool=bestpractice.com
[12]Killick SB, Ingram W, Culligan D, et al. British Society for Haematology guidelines for the management of adult myelodysplastic syndromes. Br J Haematol. 2021 Jul;194(2):267-81.
https://onlinelibrary.wiley.com/doi/10.1111/bjh.17612
http://www.ncbi.nlm.nih.gov/pubmed/34180045?tool=bestpractice.com
[13]National Cancer Institute; Surveillance, Epidemiology, and End Results program (SEER). SEER*Explorer: an interactive website for SEER cancer statistics. Apr 2023 [internet publication].
https://seer.cancer.gov/statistics-network/explorer
In the US, the incidence of MDS is approximately 4 per 100,000 (based on 2016-2020 data), which rises to approximately 40 per 100,000 in those aged ≥75 years.[13]National Cancer Institute; Surveillance, Epidemiology, and End Results program (SEER). SEER*Explorer: an interactive website for SEER cancer statistics. Apr 2023 [internet publication].
https://seer.cancer.gov/statistics-network/explorer
Incidence in the UK and Europe appear to be similar to the US.[10]Roman E, Smith A, Appleton S, et al. Myeloid malignancies in the real-world: occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol. 2016 Jun;42:186-98.
https://www.sciencedirect.com/science/article/pii/S1877782116300364
http://www.ncbi.nlm.nih.gov/pubmed/27090942?tool=bestpractice.com
The incidence of MDS is believed to be rising, in part due to an increase in the incidence of secondary MDS (e.g., following exposure to chemotherapy or radiotherapy) and an ageing population.[14]Ma X. Epidemiology of myelodysplastic syndromes. Am J Med. 2012 Jul;125(7 suppl):S2-5.
https://www.doi.org/10.1016/j.amjmed.2012.04.014
http://www.ncbi.nlm.nih.gov/pubmed/22735748?tool=bestpractice.com
However, accurate data are difficult to obtain.
MDS in younger adults and children is relatively rare, and is often associated with congenital disorders (e.g., Down syndrome, Fanconi syndrome, Bloom syndrome).[15]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: myelodysplastic syndromes [internet publication].
https://www.nccn.org/guidelines/category_1
[16]Fenaux P, Haase D, Santini V, et al; ESMO Guidelines Committee. Myelodysplastic syndromes: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Feb;32(2):142-56.
https://www.annalsofoncology.org/article/S0923-7534(20)43129-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33221366?tool=bestpractice.com
[17]Xavier AC, Kutny M, Costa LJ. Incidence and outcomes of paediatric myelodysplastic syndrome in the United States. Br J Haematol. 2018 Mar;180(6):898-901.
https://www.doi.org/10.1111/bjh.14460
http://www.ncbi.nlm.nih.gov/pubmed/28240841?tool=bestpractice.com
[18]Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017 Jan;17(1):5-19.
http://www.ncbi.nlm.nih.gov/pubmed/27834397?tool=bestpractice.com
In Asian countries, the average age at which patients are diagnosed is much younger than in other countries.[16]Fenaux P, Haase D, Santini V, et al; ESMO Guidelines Committee. Myelodysplastic syndromes: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Feb;32(2):142-56.
https://www.annalsofoncology.org/article/S0923-7534(20)43129-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33221366?tool=bestpractice.com
While the reason for this difference is unclear, chemical contamination and infectious causes in addition to ethnic differences may contribute.[19]Chen B, Zhao WL, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia. 2005 May;19(5):767-75.
http://www.ncbi.nlm.nih.gov/pubmed/15759035?tool=bestpractice.com